Aptuit, Inc.

Also on record

Records under this name other than the patents Aptuit, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Aptuit, Inc.

Patent	Title	Status	Expires	Confidence
US 8,163,790	Metronidazole Cocrystals and Imipramine Cocrystals now held by New Form Pharmaceuticals Inc. In force Term ends Jun 1, 2028 · High confidence	In force	Term ends Jun 1, 2028	High confidence
US 9,156,756	Efficient Process to Induce Enantioselectivity in Procarbonyl Compounds now held by Laurus Labs Limited In force Term ends Jul 30, 2028 · High confidence	In force	Term ends Jul 30, 2028	High confidence
US 8,018,588	Sample Holder and Sample Preparation Device now held by Curia Global, Inc. In force Term ends Jan 1, 2029 · High confidence	In force	Term ends Jan 1, 2029	High confidence
US 8,389,778	Preparation of Mannitol Modification III now held by Curia Global, Inc. In force Term ends Feb 20, 2029 · High confidence	In force	Term ends Feb 20, 2029	High confidence
US 8,067,429	Forms of Rifaximin and Uses Thereof conveyed to Salix Pharmaceuticals Ltd. - now held by Salix Pharmaceuticals, Inc. In force Term ends Feb 25, 2029 · High confidence	In force	Term ends Feb 25, 2029	High confidence
US 8,569,326	Forms of Rifaximin and Uses Thereof now held by Salix Pharmaceuticals, Ltd. In force Ends no later than Feb 25, 2029 · Low confidence	In force	Ends no later than Feb 25, 2029	Low confidence
US 9,273,066	Forms of Rifaximin and Uses Thereof now held by Salix Pharmaceuticals, Ltd. In force Ends no later than Feb 25, 2029 · Low confidence	In force	Ends no later than Feb 25, 2029	Low confidence
US 9,359,357	Forms of Rifaximin and Uses Thereof conveyed to Salix Pharmaceuticals Ltd. - now held by Alfa Wassermann S.P.A. In force Term ends Feb 25, 2029 · Medium confidence	In force	Term ends Feb 25, 2029	Medium confidence
US 9,546,183	Forms of Rifaximin and Uses Thereof now held by Salix Pharmaceuticals, Ltd. In force Ends no later than Feb 25, 2029 · Low confidence	In force	Ends no later than Feb 25, 2029	Low confidence
US 9,700,545	Forms of Rifaximin and Uses Thereof conveyed to Salix Pharmaceuticals Ltd. - now held by Salix Pharmaceuticals, Inc. In force Term ends Feb 25, 2029 · Low confidence	In force	Term ends Feb 25, 2029	Low confidence

10 of 71 records shown.

Pro members see all 71.

Pro members: see all 71 records